Sanofi announced Friday that the FDA has granted its allergy spray Nasacort approval to be sold over the counter in drugstores. The medication, which was approved to treat adults and children 2 and older with allergies, was the first steroid nasal spray to attain clearance for OTC use.

Related Summaries